12.53
price down icon0.95%   -0.1158
 
loading

Dyne Therapeutics Inc Azioni (DYN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
5.38%
115.79
122.37 97.11 105.66 71.96
Operating Income/Loss
5.38%
-115.79
-122.37 -97.11 -105.66 -71.96
Income/Loss From Continuing Operations Before Tax
3.90%
-110.86
-115.36 -89.54 -97.12 -65.10
Income/Loss From Continuing Operations After Tax
3.90%
-110.86
-115.36 -89.54 -97.12 -65.10
Net Income/Loss
3.90%
-110.86
-115.36 -89.54 -97.12 -65.10
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
7.62%
-0.97
-1.05 -0.88 -0.96 -0.70
Diluted Earnings Per Share
7.62%
-0.97
-1.05 -0.88 -0.96 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.83
price up icon 1.66%
$85.75
price up icon 1.10%
$31.38
price up icon 2.25%
$102.62
price up icon 4.05%
$144.22
price up icon 0.15%
biotechnology ONC
$342.98
price up icon 0.67%
Capitalizzazione:     |  Volume (24 ore):